Aspiriant, LLC Danaher Corp Transaction History

Aspiriant, LLC

$2.61 Billion
Q3 2024

A detailed history of Aspiriant, LLC transactions in Danaher Corp stock. As of the latest transaction made, Aspiriant, LLC holds 5,514 shares of DHR stock, worth $1.3 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

5,514

Previous 5,570 1.01%

Holding current value

$1.3 Million

Previous $1.39 Million 10.14%

% of portfolio

0.06%

Previous 0.06%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 17, 2024	SELL	$239.25 - $280.76 $13,398 - $15,722	-56 Reduced 1.01%	5,514 $1.53 Million
Q2 2024 Jul 15, 2024	SELL	$235.51 - $267.98 $225,147 - $256,188	-956 Reduced 14.65%	5,570 $1.39 Million
Q1 2024 Apr 15, 2024	SELL	$224.58 - $256.19 $13,923 - $15,883	-62 Reduced 0.94%	6,526 $1.63 Million
Q4 2023 Jan 26, 2024	BUY	$185.1 - $233.13 $4,997 - $6,294	27 Added 0.41%	6,588 $1.52 Million
Q3 2023 Oct 17, 2023	BUY	$233.08 - $265.59 $20,044 - $22,840	86 Added 1.33%	6,561 $1.63 Million
Q2 2023 Jul 19, 2023	SELL	$224.99 - $256.14 $95,845 - $109,115	-426 Reduced 6.17%	6,475 $1.55 Million
Q1 2023 Apr 27, 2023	SELL	$239.75 - $277.0 $47,470 - $54,846	-198 Reduced 2.79%	6,901 $1.74 Million
Q4 2022 Jan 23, 2023	BUY	$241.42 - $282.29 $45,869 - $53,635	190 Added 2.75%	7,099 $0
Q3 2022 Oct 28, 2022	BUY	$247.06 - $1507.4 $40,764 - $248,721	165 Added 2.45%	6,909 $1.79 Million
Q2 2022 Jul 25, 2022	SELL	$237.11 - $299.66 $30,112 - $38,056	-127 Reduced 1.85%	6,744 $1.71 Million
Q1 2022 May 06, 2022	SELL	$257.27 - $315.76 $52,740 - $64,730	-205 Reduced 2.9%	6,871 $2.01 Million
Q4 2021 Feb 14, 2022	BUY	$292.08 - $329.01 $6,425 - $7,238	22 Added 0.31%	7,076 $2.33 Million
Q3 2021 Oct 27, 2021	SELL	$272.21 - $332.43 $29,943 - $36,567	-110 Reduced 1.54%	7,054 $2.15 Million
Q2 2021 Aug 13, 2021	SELL	$225.08 - $271.69 $19,356 - $23,365	-86 Reduced 1.19%	7,164 $1.92 Million
Q1 2021 May 11, 2021	SELL	$212.38 - $245.9 $38,865 - $44,999	-183 Reduced 2.46%	7,250 $1.63 Million
Q4 2020 Feb 01, 2021	SELL	$212.5 - $245.46 $125,587 - $145,066	-591 Reduced 7.37%	7,433 $1.65 Million
Q3 2020 Oct 29, 2020	SELL	$177.16 - $215.33 $67,675 - $82,256	-382 Reduced 4.54%	8,024 $1.73 Million
Q2 2020 Aug 06, 2020	SELL	$128.7 - $176.83 $73,873 - $101,500	-574 Reduced 6.39%	8,406 $1.48 Million
Q1 2020 May 05, 2020	SELL	$121.39 - $169.05 $256,254 - $356,864	-2,111 Reduced 19.03%	8,980 $1.24 Million
Q4 2019 Jan 27, 2020	SELL	$133.47 - $153.48 $104,773 - $120,481	-785 Reduced 6.61%	11,091 $1.7 Million
Q3 2019 Nov 04, 2019	SELL	$135.4 - $146.47 $105,341 - $113,953	-778 Reduced 6.15%	11,876 $1.72 Million
Q2 2019 Aug 06, 2019	SELL	$124.88 - $143.73 $142,363 - $163,852	-1,140 Reduced 8.26%	12,654 $1.81 Million
Q1 2019 May 03, 2019	SELL	$97.62 - $132.29 $163,513 - $221,585	-1,675 Reduced 10.83%	13,794 $1.82 Million
Q4 2018 Feb 04, 2019	SELL	$94.85 - $109.54 $210,851 - $243,507	-2,223 Reduced 12.57%	15,469 $1.6 Million
Q3 2018 Oct 26, 2018	SELL	$98.13 - $108.9 $167,998 - $186,436	-1,712 Reduced 8.82%	17,692 $1.92 Million
Q2 2018 Aug 07, 2018	SELL	$96.1 - $103.24 $92,832 - $99,729	-966 Reduced 4.74%	19,404 $1.92 Million
Q1 2018 May 04, 2018	BUY	$92.16 - $103.8 $1.62 Million - $1.83 Million	17,612 Added 638.58%	20,370 $1.99 Million
Q4 2017 Jan 31, 2018	SELL	$85.26 - $94.62 $1.82 Million - $2.03 Million	-21,405 Reduced 88.59%	2,758 $256,000
Q3 2017 Nov 13, 2017	BUY	$79.29 - $88.45 $1.92 Million - $2.14 Million	24,163	24,163 $2.07 Million

Others Institutions Holding DHR

# of Institutions

2,508

Shares Held

542M

Call Options Held

7.07M

Put Options Held

4.55M

View Full List

About DANAHER CORP

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $171B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

More about DHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aspiriant, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aspiriant, LLC with notifications on news.

Account